跳到主要內容區塊
Left menu Right menu close
fastmenu
請將裝置改以直向瀏覽，以獲得最佳效果。

請將裝置改以直向瀏覽，以獲得最佳效果。

:::

Chang Hwa Bank announced the Board of Directors’ resolution to invest in TaiAx Life Science Fund L.P.

  1. 1.Name and nature of the underlying security (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield): TaiAx Life Science Fund L.P. 
  2. 2.Date of occurrence of the event:2024/04/18 
  3. 3.No., unit price, and monetary amount of the transaction: 
  4. (1) Volume、Unit price: N/A(due to the nature of Limited Partnership) 
  5. (2) Total monetary amount: No more than USD$5 million. 
  6. 4.Counterparty to the trade and its relationship to the company (if the trading counterparty is a natural person and not a related party of the company, its name is not required to be disclosed):
  7. (1)Counterparty: TaiAx Life Science Fund L.P. 
  8. (2)Relationship with the Company: Related party, one of our directors also invests in the counterparty
  9. 5.Where the counterparty to the trade is a related party, an announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, including its relationship with the company and the trading counterparty, the price of the ownership transfer, and date of transfer: 
  10. (1) The reason for choosing the related party as trading counterparty: To generate more investment income 
  11. (2) Previous owner: N/A 
  12. (3) Relationship of the previous owner with the Company and the trading counterparty: N/A 
  13. (4) Price of transfer, and date of acquisition:N/A 
  14. 6.Where the owner of the underlying securities within the past five years has been a related party of the company, an announcement shall also include the dates and prices of acquisition and disposal by the related party and its relationship with the company at the time:N/A 
  15. 7.Matters related to the creditor’s rights currently being disposed of (including type of collateral of the disposed creditor’s rights; if the creditor’s rights are creditor’s rights over a related party, the name of the related party and the book amount of such creditor’s rights currently being disposed of must also be announced):N/A 
  16. 8.Profit (or loss) from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained):N/A 
  17. 9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations: 
  18. (1) Terms of delivery or payment :Capital contributions according to the capital call notices after approval by the competent authority. 
  19. (2) Restrictive covenants in the contract, and other important stipulations: According to the Limited Partnership Agreement. 
  20. 10.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making unit: 
  21. (1) The manner in which the current transaction was decided: Follow the authorization procedure of company. 
  22. (2) The reference basis for the decision on price: No unit price due to the nature of limited partnership.
  23. (3) The decision-making unit: Board of Directors 
  24. 11.Net worth per share of company of the underlying securities acquired or disposed of:N/A 
  25. 12.The discrepancy between the reference price of private placement company and the transaction amount per share is 20 percent or more:N/A 
  26. 13.Current cumulative no., amount, and shareholding ratio of the securities being traded (including the current transaction) as of the date of occurrence and status of any restriction of rights (e.g.,pledges):
  27. (1) Current cumulative no. of shares held (including the current transaction) : N/A(due to the nature of Limited Partnership) 
  28. (2) Current cumulative monetary amount (including the current transaction): no more than USD$5 million. 
  29. (3) Shareholding percentage (including the current transaction): 2.5% (provisional) 
  30. (4) Status of any restriction of rights: N/A 
  31. 14.Privately placed securities (including the current transaction) as a percentage of total assets of the company and shareholder’s equity of the parent company on the latest financial statements, and the operating capital on the latest financial statements as of the date of occurrence: 
  32. (1)Total Assets:0.01% 
  33. (2)Shareholder's Equity:0.22% 
  34. (3)Operating Capital:NA 
  35. 15.Broker and broker's fee:N/A 
  36. 16.Concrete purpose or use of the acquisition or disposition: Long term investments. 
  37. 17.Whether the directors expressed any objection to the present transaction: None 
  38. 18.Whether the trading counterparty is a related party:Yes 
  39. 19.Date of approval by board of directors:2024/04/18 
  40. 20.Recognition date by supervisors or approval date by audit committee:NA 
  41. 21.Whether the CPA issued an opinion on the unreasonableness of the current transaction:N/A
  42. 22.Name of the CPA firm:N/A 
  43. 23.Name of the CPA:N/A 
  44. 24.License no.of the CPA:N/A 
  45. 25.Any other matters that need to be specified: 
  46. (1)The investment is only effective after the approval of the competent authority. 
  47. (2)The amount is converted to NTD based on the exchange rate of 1 USD to 32.005 NTD as of March 29,2024.
Chang Hwa Bank logo

© CHB All rights reserved.

Customer service center single representative number：+886-412-2222

Mobile please dial +886-2-412-2222/0800-365-889(Local call only)

Back to top